Showing results (161-170 of 2,329) with videos related to

Sort By:
Pageof 233
Clinical Drug Investigation|March 29, 2008
Drug use and low blood pressure in the elderly: a study of data from the kungsholmen projectG Passare, Z Guo, B Winblad, et al.
Clinical Drug Investigation|March 29, 2008
Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcomeM Pirisi, R Faedda, A Satta, et al.
Clinical Drug Investigation|March 29, 2008
Lamotrigine in multihandicapped therapy-resistant epileptic patientsB Huber, T May, M Seidel
Clinical Drug Investigation|March 29, 2008
Clopidogrel activities in patients with renal function impairmentG Deray, C Bagnis, R Brouard, et al.
Clinical Drug Investigation|February 26, 2014
Cost effectiveness of fesoterodine and tolterodine for the treatment of overactive bladder with urge urinary incontinence in Spain and FinlandJavier C Angulo, Antti Valpas, Javier Rejas, et al.
Clinical Drug Investigation|March 11, 2014
Comparative Study of Teicoplanin vs Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus BacteraemiaC Y Liu, W S Lee, C P Fung, et al.
Clinical Drug Investigation|March 11, 2014
Kapanol™ capsules : pellet formulation provides alternative methods of administration of sustained-release morphine sulfateR Jones, E Hale, L Talomsin, et al.
Clinical Drug Investigation|March 14, 2014
Pharmacodynamics, pharmacokinetics, and tolerability of intravenous or subcutaneous GC1113, a novel erythropoiesis-stimulating agentHyeKyung Han, Jongtae Lee, Donghoon Shin, et al.
Clinical Drug Investigation|January 20, 2017
Predictors of the Usefulness of Corticosteroids for Cancer-Related Fatigue in End-of-Life PatientsYuko Kanbayashi, Toyoshi Hosokawa
Clinical Drug Investigation|January 20, 2017
US FDA Perspective on Elbasvir/Grazoprevir Treatment for Patients with Chronic Hepatitis C Virus Genotype 1 or 4 InfectionSarita D Boyd, LaRee Tracy, Takashi E Komatsu, et al.
Pageof 233